Study on clinical presentation of malaria and response to antimalarial treatment in children less than twelve years
DOI:
https://doi.org/10.18203/2349-3291.ijcp20232586Keywords:
Severe malaria, Pallor, Falciparum, Chloroquine, FeverAbstract
Background: In the tropical country of India, malaria in pediatric age group is one of the most important cause of mortality and morbidity. The study aimed to identify the clinicoepidemiologic features and response to antimalarial treatment in the children.
Methods: Prospective analytical study conducted for the same over the period of two years in tertiary care hospital (September 2019 to September 2021). All children under twelve years hospitalised with fever and were diagnosed to have malaria by Peripheral smear or RDT were included in the study after ethical clearance and parental consent. Total sample size was 90.
Results: Incidence of the malarial disease among total admitted patients in our study period was found to be 3.5%. The highest percentage of patients with malaria belonged to age group of 13m to 5 years (40%) and least being the age group 10-12years (7.7%). In study fever was found to be the major chief complaint followed by chills and rigor. Bleeding diathesis was least common It was found out from our study that overall most common clinical finding in the study patients was anemia or pallor with an overall of 35 patients (38.8%). Almost 73.3% (66) patients had anemia out of which 14.4% (13 patients) overall where found to have severe anemia and 27.7% (25) had moderate anemia and 31.1% (28 patients) had mild anemia. 27.7% (25) cases satisfied one or more WHO criteria for severe malaria.
Conclusions: The emergence of severe malaria caused by P. vivax could have significant implications in planning the malaria-control programmes for the community. The widespread use of ACT for severe malaria as per the guidelines of the WHO could result in the emergence of resistant parasite strains. It may be rational to continue the use of chloroquine for malaria due to P. vivax in chloroquine-sensitive areas. In places where both P. vivax and P. falciparum co-exist, measures need to be equally targeted to P. vivax to decrease morbidity and mortality due to severe malaria.
References
Kochar DK, Tanwar GS, Khatri PC, Kochar SK, Sengar GS, Gupta A, et al. Clinical features of children hospitalized with malaria--a study from Bikaner, northwest India. Am J Trop Med Hyg. 2010;83(5):981-9.
Gomber S, Kabilan L. Prevalence of malaria in East Delhi-a hospital based study. Indian Pediatr. 1999; 36(6):579-80.
Fernando SD, Rodrigo C, Rajapakse S. The 'hidden' burden of malaria: cognitive impairment following infection. Malar J. 2010;9:366.
Lalloo DG, Shingadia D, Bell DJ, Beeching NJ, Whitty CJM, Chiodini PL; PHE Advisory Committee on Malaria Prevention in UK Travellers. UK malaria treatment guidelines 2016. J Infect. 2016;72(6):635-49.
Gehlawat VK, Arya V, Kaushik JS, Gathwala G. Clinical spectrum and treatment outcome of severe malaria caused by Plasmodium vivax in 18 children from northern India. Pathog Glob Health. 2013;107(4): 210-4.
Messina JP, Taylor SM, Meshnick SR, Linke AM, Tshefu AK, Atua B, et al. Population, behavioural and environmental drivers of malaria prevalence in the Democratic Republic of Congo. Malar J. 2011;10:161.
Kokwaro G. Ongoing challenges in the management of malaria. Malar J. 2009;8:2.
Wang SJ, Lengeler C, Smith TA, Vounatsou P, Diadie DA, et al. Rapid urban malaria appraisal (RUMA) I: epidemiology of urban malaria in Ouagadougou. Malar J. 2005;4:43.
Macintyre K, Keating J, Sosler S, Kibe L, Mbogo CM, et al. Examining the determinants of mosquito-avoidance practices in two Kenyan cities. Malar J. 2002;1:1-14.
Guyatt HL, Corlett SK, Robinson TP, Ochola SA, Snow RW. Malaria prevention in highland Kenya: indoor residual house spraying vs insecticide- treated bed nets. Trop Med Int Health. 2002;7:298-303.
Raju MH, Ganesh N, Kumar KK, Sowjanya M, Satish PV, Sunita K. A study on prevalence of malaria in different mandals of east Godavari district, Andhra Pradesh, India. Int J Res Sci Technol. 2014;3(6):74-7.
Takshande A, Vilhekar K, Jain M, Atkari S. Clinicohematological profile of cerebral malaria in a rural hospital. J Indian Acad Clin Med. 2006;7:308-12.
Price RN, Simpson JA, Nosten F, Luxemburger C, Hkirjaroen L, Ter Kuile F, et al. Factors contributing to anemia after uncomplicated falciparum malaria. Am J Trop Med Hyg. 2001;65(5):614-22.
Gohiya P, Goel M, Dwevedi R, Renwal S. Clinical profile and prognostic indicators of Plasmodium Falciparum Malaria in children (1-12 Years). Int J Med Res. 2014;2(3):23-9.
Rasheed A, Saeed S, Khan SA. Clinical and laboratory findings in acute malaria caused by various plasmodium species. J Pak Med Assoc. 2009;59(4): 220-3.
Taviad PP, Javadekar TB, Selot BA, Chaudhary VP. Socio Demographic and clinical features of the Malaria Cases. Nat J Community Med. 2012;3(1):94-6.
Zimmerman PA, Mehlotra RK, Kasehagen LJ, Kazura JW. Why do we need to know more about mixed Plasmodium species infections in humans? Trends Parasitol. 2004;20(9):440-7.
Anstey NM, Handojo T, Pain MC, Kenangalem E, Tjitra E, Price RN, Maguire GP. Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation. J Infect Dis. 2007;195(4):589-96.
Lacerda MV, Mourão MP, Alexandre MA, Siqueira AM, Magalhães BM, Martinez-Espinosa FE, et al. Understanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literature. Malar J. 2012; 11:12.
Gohiya P, Goel M, Dwevedi R, Renwal S. Clinical profile and prognostic indicators of Plasmodium Falciparum Malaria in children (1-12 Years). Int J Med Res Rev. 2014;30;2. [PubMed]
Rasheed A, Saeed S, Khan SA. Clinical and laboratory findings in acute malaria caused by various plasmodium species. J Pak Med Assoc. 2009;59(4): 220-3.
Saira M, Rajkumar MM, Mohammad MT: clinical manifestations and predictors of mortality in severe malaria in children. Sch J App Med Sci. 2016;4(6): 1931-5.
Sodeinde O. Glucose-6-phosphate dehydrogenase deficiency. Baillieres Clin Haematol. 1992;5(2):367-82.
Taviad PP, Javadekar TB, Selot BA, Chaudhary VP. Socio Demographic and clinical features of the Malaria Cases. Nat J Community Med. 2012;3(1):94-6.
Luxembourger C, Ricci F, Nosten F, Raimond D, Bathet S, et al. The epidemiology of severe malaria in an area of low transmission in Thailand. Trans R Soc Trop Med Hyg. 2007;91:256-62.
Price RN, Simpson JA, Nosten F, Luxemburger C, Hkirjaroen L. Factors contributing to anemia after uncomplicated falciparum malaria. Am J Trop Med Hyg. 2001;65:614-22.
